Chiron Real Estate
XRN on NYSE. Chiron Real Estate Inc. leases medical buildings to physician groups and health systems. Market value $448m.
Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.
Cash flow or capital spending isn't reported, so free cash flow is unknown.
Recent profit includes a one-time gain, so we price the company excluding that gain.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
See Real estate stocks that passed both tests
This is not advice. Check the numbers below.
We could not compute this from the filings.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: not known. Price score: not known. Our list needs 70 on quality and 60 on price.
$33.81 a share, 16% above its 1-year low
Over the past year the price has ranged from $29.05 to $38.65.
Dividend: 1.3% a year
Paid every year for at least 5 years
Prices from Monday’s close (5 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $116m | $137m | $141m | $139m | $148m |
| Operating margin | |||||
| Operating margin | n/a | n/a | n/a | n/a | n/a |
| Debt to equity | |||||
| Debt to equity | n/a | n/a | n/a | 0.03 | 0.00 |
| Shares outstanding | |||||
| Shares outstanding | 0.07bn | 0.07bn | 0.07bn | 0.01bn | 0.01bn |
Health checks
- Free cash flow positiveNot enough data
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)5 of 7 checks we could run
- Profit backed by cash (accruals)Yes
- Debt0.00× equity
- Revenue growth, five yearsSlow, 9.6% a year
- Buying back its own sharesYes, 80% fewer since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $40 million last quarter, up 5% on a year ago.
- Profit: $63 million, after a loss of $800,000 a year ago.
- 1% fewer shares than a year ago. Each share owns a bit more of the company.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $34m |
| December 2024 | $35m |
| March 2025 | $35m |
| June 2025 | $38m |
| September 2025 | $37m |
| December 2025 | $38m |
| March 2026 | $38m |
| June 2026 | $40m |
| Quarter to | Amount |
|---|---|
| September 2024 | $2m |
| December 2024 | $1m |
| March 2025 | $2m |
| June 2025 | -$800,000 |
| September 2025 | -$6m |
| December 2025 | -$7m |
| March 2026 | -$749,000 |
| June 2026 | $63m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 2 March 2026
- Next quarterly (estimated, 10-Q)
- 9 November 2026
Who owns it
4 long-term investors we follow own it, unchanged from 4 last quarter. 170 funds in all.
- LSV Asset ManagementJosef Lakonishok
- Value
- $6m
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Heartland AdvisorsBill Nasgovitz | $21m | 0.9% | Added |
| Hotchkis & WileyHotchkis & Wiley team | $6m | <0.1% | Added |
| LSV Asset ManagementJosef Lakonishok | $6m | <0.1% | |
| GAMCO InvestorsMario Gabelli | $668,194 | <0.1% | Added |
Largest holders overall
- BlackRock$67mAdded
- Vanguard Portfolio Management$25mAdded
- Heartland Advisors$21mAdded
- Vanguard Capital Management$21m
- Alyeska Investment Group, L.P.$16mAdded
- Newtyn Management$15mNew
- Geode Capital Management$14mAdded
- State Street$13m
- Uniplan Investment Counsel$11mAdded
- Stifel Financial$10m
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
1 investor owns more than 5%.
- Vanguard Portfolio ManagementPassive investor5.0%Since 30 June 2026
- PRUDENTIAL FINANCIAL INCPassive investorSold down below 5%Since 30 September 2025
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Vanguard Portfolio Management Passive investor | 5.0% | 30 June 2026 | |
PRUDENTIAL FINANCIAL INC Passive investor | Sold down below 5% | 30 September 2025 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 12 insiders bought $4m of shares on the open market.
- Whitlock Matthew FitzsimmonsChief Investment OfficerBought
- Date
- 17 August 2026
- Shares
- 500
- Price
- $36.38
- Value
- $18,190
- Whitlock Matthew FitzsimmonsChief Investment OfficerBought
- Date
- 14 August 2026
- Shares
- 500
- Price
- $37.21
- Value
- $18,605
- Roseth Aaron RobertCOO, DirectorBought
- Date
- 12 August 2026
- Shares
- 13,500
- Price
- $36.73
- Value
- $495,855
- Decker Mark Okey JrCEO and President, DirectorBought
- Date
- 11 August 2026
- Shares
- 6,875
- Price
- $35.92
- Value
- $246,950
- Decker Mark Okey JrCEO and President, DirectorBought
- Date
- 11 August 2026
- Shares
- 550
- Price
- $36.00
- Value
- $19,800
- Fitzgerald CharlesDirectorBought
- Date
- 11 August 2026
- Shares
- 14,000
- Price
- $35.78
- Value
- $500,920
- Decker Mark Okey JrCEO and President, DirectorBought
- Date
- 10 August 2026
- Shares
- 8,000
- Price
- $35.88
- Value
- $287,040
- Fitzgerald CharlesDirectorBought
- Date
- 10 August 2026
- Shares
- 27,600
- Price
- $35.94
- Value
- $991,944
- Cypher MatthewDirectorBought
- Date
- 14 May 2026
- Shares
- 1,420
- Price
- $35.12
- Value
- $49,870
- Wittman LoriDirectorBought
- Date
- 12 May 2026
- Shares
- 2,940
- Price
- $33.85
- Value
- $99,519
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 17 August 2026 | Whitlock Matthew Fitzsimmons Chief Investment Officer | Bought | 500 | $36.38 | $18,190 |
| 14 August 2026 | Whitlock Matthew Fitzsimmons Chief Investment Officer | Bought | 500 | $37.21 | $18,605 |
| 12 August 2026 | Roseth Aaron Robert COO, Director | Bought | 13,500 | $36.73 | $495,855 |
| 11 August 2026 | Decker Mark Okey Jr CEO and President, Director | Bought | 6,875 | $35.92 | $246,950 |
| 11 August 2026 | Decker Mark Okey Jr CEO and President, Director | Bought | 550 | $36.00 | $19,800 |
| 11 August 2026 | Fitzgerald Charles Director | Bought | 14,000 | $35.78 | $500,920 |
| 10 August 2026 | Decker Mark Okey Jr CEO and President, Director | Bought | 8,000 | $35.88 | $287,040 |
| 10 August 2026 | Fitzgerald Charles Director | Bought | 27,600 | $35.94 | $991,944 |
| 14 May 2026 | Cypher Matthew Director | Bought | 1,420 | $35.12 | $49,870 |
| 12 May 2026 | Wittman Lori Director | Bought | 2,940 | $33.85 | $99,519 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
The company just told the SEC about a big change. The deep dive shows what it means for the price you pay.
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.